Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06336005
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-03-22
Brief Title:
A Study to See How Safe a New Medicine NNC6022-0001 is in Healthy People
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A First Human Dose Study to Assess the Safety Tolerability Pharmacokinetics and Target Engagement of Single Doses of NNC6022-0001 in Healthy Adults
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is testing a new study medicine which is being tested as a potential medicine to treat cardiometabolic diseases
The aim of this study is to see if the study medicine is safe how it works in participants body and what the body does to the study medicine
Participants will either get NNC6022-0001 the new study medicine or placebo a dummy medicine without the active ingredient Which treatment participants get is decided by chance The study medicine is a potential new medicine which cannot be prescribed by doctors
The study will last for about 10 months in total
The aim of this study is to see if the study medicine is safe how it works in participants body and what the body does to the study medicine
Participants will either get NNC6022-0001 the new study medicine or placebo a dummy medicine without the active ingredient Which treatment participants get is decided by chance The study medicine is a potential new medicine which cannot be prescribed by doctors
The study will last for about 10 months in total
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None